Lipopharma

Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases.

Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses its activities on the discovery, rational design and clinical development of a new generation of medicines that act through the selective regulation of membrane lipids, a novel therapeutic strategy known as “Membrane Lipid Therapy” (MLT). Lipopharma arose as an academic spin-off, founded to turn new scientific breakthroughs and discoveries made by scientists at the Institute of Health Science Research (IUNICS - part of the University of the Balearic Islands in Mallorca, Spain) into a new class of innovative lipid regulator therapeutic agents that they believe have dramatic game-changing potential in the treatment of life-threatening conditions like cancer, CNS, inflammatory or metabolic diseases